Bolus administration of intravenous glucose in the treatment of hyperkalemia: A randomized controlled trial

Nephron - Physiology

Volumn 126, Issue 1, 2014, Pages 1-8

  Chothia, Mogamat Yazied ^a   Halperin, Mitchell L ^c,d   Rensburg, Megan A ^a   Hassan, Mogamat Shafick ^b   Davids, Mogamat Razeen ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Clinical trial; Glucose; Hyperkalemia; Hypoglycemia; Insulin

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC DYSFUNCTION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; LUNG EDEMA; MALE; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GLUCOSE HOMEOSTASIS; HEMODIALYSIS; INSULIN RESISTANCE; INTERVENTION STUDY;

ADMINISTRATION, INTRAVENOUS; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOSE; HUMANS; HYPERKALEMIA; INSULIN; KIDNEY FAILURE, CHRONIC; MALE; POTASSIUM; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84895675164     PISSN: None     EISSN: 16602137     Source Type: Journal    
DOI: 10.1159/000358836     Document Type: Article

References (41)

1. Acker CG, Johnson JP, Palevsky PM, Greenberg A: Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158: 917-924. (Pubitemid 28183648)
2. Stevens MS, Dunlay RW: Hyperkalemia in hospitalized patients. Int Urol Nephrol 2000; 32: 177-180. (Pubitemid 32140484)
3. Kamel KS, Wei C: Controversial issues in the treatment of hyperkalaemia. Nephrol Dial Transplant 2003; 18: 2215-2218. (Pubitemid 37336805)
4. Schwarz KC, Cohen BD, Lubash GD, Rubin AL: Severe acidosis and hyperpotassemia treated with sodium bicarbonate infusion. Circulation 1959; 19: 215-220.
5. Danowski TS, Greenman L, Mateer FM, Parsons WB, Weigand FA, Mermelstein H, Peters JH: Carboxylic cation exchange resin effects in dogs. J Clin Invest 1951; 30: 984-994.
6. Gruy-Kapral C, Emmett M, Santa Ana CA, Porter JL, Fordtran JS, Fine KD: Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 1998; 9: 1924-1930. (Pubitemid 28443490)
7. Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM: Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 1987; 101: 267-272. (Pubitemid 17065234)
8. Gerstman BB, Kirkman P, Platt R: Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 1992; 20: 159-161.
9. McGowan CE, Saha S, Chu G, Resnick MB, Moss SF: Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. South Med J 2009; 102: 493-497.
10. Sterns RH, Rojas M, Bernstein P, Chennupati S: Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 2010; 21: 733-735.
11. Kamel KS, Schreiber M: Asking the question again: are cation exchange resins effective for the treatment of hyperkalemia? Nephrol Dial Transplant 2012; 27: 4294-4297.
12. Rosi? N, Standaert M, Pollet R: The mechanism of insulin stimulation of (Na + , K + )-ATPase transport activity in muscle. J Biol Chem 1985; 260: 6206-6212.
13. Blumberg A, Weidmann P, Shaw S, Gnädinger M: Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988; 85: 507-512.
14. Lens XM, Montoliu J, Cases A, Campistol JM, Revert L: Treatment of hyperkalemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant 1989; 4: 228-232. (Pubitemid 19113609)
15. Allon M, Copkney C: Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990; 38: 869-872. (Pubitemid 20362856)
16. Mahajan S, Mangla M, Kishore K: Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients. J Assoc Physicians India 2001; 49: 1082-1085. (Pubitemid 33645107)
17. Williams PS, Davenport A, Bone JM: Hypoglycaemia following treatment of hyperkalaemia with insulin and dextrose. Postgrad Med J 1988; 64: 30-32. (Pubitemid 18059295)
18. Schafers S, Naunheim R, Vijayan A, Tobin G: Incidence of hypoglycemia following insulinbased acute stabilization of hyperkalemia treatment. J Hosp Med 2012; 7: 239-242.
19. Tarail R, Seldin DW, Goodyear AV: Effects of injection of hypertonic glucose on metabolism of water and electrolytes in patients with edema. J Clin Invest 1951; 30: 1111-1119.
20. Groen J, Willebrands AF, Kamminga CE, Van Schothorst HK, Godfried EG: Effects of glucose administration on the potassium and inorganic phosphate content of the blood serum and the electrocardiogram in normal individuals and in non-diabetic patients. Acta Med Scand 1952; 141: 352-366.
21. Marks PA, Bishop JS: The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test. J Clin Invest 1957; 36: 254-264.
22. Muto S, Sebata K, Watanabe H, Shoji F, Yamamoto Y, Ohashi M, Yamada T, Matsumoto H, Mukouyama T, Yonekura T, Namiki S, Kusano E: Effect of oral glucose administration on serum potassium concentration in hemodialysis patients. Am J Kidney Dis 2005; 46: 697-705. (Pubitemid 41383948)
23. Evans KJ, Greenberg A: Hyperkalemia: a review. J Intensive Care Med 2005; 20: 272-290. (Pubitemid 43080638)
24. Weisberg LS: Management of severe hyperkalemia. Crit Care Med 2008; 36: 3246-3251.
25. DeFronzo RA, Andres R, Edgar P, Walker WG: Carbohydrate metabolism in uremia: a review. Medicine (Baltimore) 1973; 52: 469-481.
26. Porte DJ: Sympathetic regulation of insulin secretion. Arch Intern Med 1969; 123: 252-260.
27. Goldfarb S, Cox M, Singer I, Goldberg M: Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med 1976; 84: 426-432.
28. Ammon RA, May WS, Nightingale SD: Glucose-induced hyperkalemia with normal aldosterone levels. Studies in a patient with diabetes mellitus. Ann Intern Med 1978; 89: 349-351. (Pubitemid 8389388)
29. Conte G, Dal Canton A, Imperatore P, De Nicola L, Gigliotti G, Pisanti N, Memoli B, Fuiano G, Esposito C, Andreucci VE: Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 1990; 38: 301-307. (Pubitemid 20324991)
30. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568. (Pubitemid 11141740)
31. Mak RH, DeFronzo RA: Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-382.
32. Alvestrand A: Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997; 62:S48-S52. (Pubitemid 27489403)
33. Alvestrand A, Wahren J, Smith D, DeFronzo RA: Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol 1984; 246:E174-E180. (Pubitemid 14147692)
34. Cheema-Dhadli S, Chong C-K, Kamel KS, Halperin ML: An acute infusion of lactic acid lowers the concentration of potassium in arterial plasma by inducing a shift of potassium into cells of the liver in fed rats. Nephron Physiol 2012; 120: 7-15.
35. Juel C, Halestrap AP: Lactate transport in skeletal muscle-role and regulation of the monocarboxylate transporter. J Physiol 1999; 517: 633-642. (Pubitemid 29306451)
36. Counillon LL, Pouyssegur RJ: The members of the Na +/H + exchanger gene family: their structure, function, expression, and regulation; in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. Philadelphia, Lippincott Williams & Wilkins, 2000, vol 1, pp 223-234.
37. Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M: Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 2014; 37: 217-225.
38. Ljutic D, Rumboldt Z: Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 1993; 15: 73-76. (Pubitemid 23054066)
39. Allon M, Shanklin N: Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 1996; 28: 508-514. (Pubitemid 26337588)
40. Kim HJ: Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996; 72: 476-482.
41. Ngugi N, McLigeyo S, Kayima J: Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East Afr Med J 1997; 74: 503.